Cantú-Maltos H, Flores-Gavilán P, Olivo-Arroyo G, Ávila-Romay A, Toussaint-Caire S, Vega-Memije ME

Language: Spanish
References: 11
Page: 177-178
PDF size: 77.00 Kb.

Text Extraction

No abstract.

REFERENCES

1. Emerson Maher E y Vidal C, Trichilemmoma, Cutis 2015; 96(2):104-6.

2. Al-Zaid T, Ditelberg J, Prieto V et al., Trichilemmomas show loss of PTEN in Cowden syndrome but only rarely in sporadic tumors, J Cutaneous Pathol 2012; 39(5):493-99.

3. Jin M, Hampel H, Pilarski R et al., Phosphatase and tensin homolog immunohistochemical staining and clinical criteria for Cowden syndrome in patients with trichilemmoma or associated lesions, Am J Dermatopathol 2013; 35(6):637-40.

4. Lai T, Huilgol S, James C et al., Trichilemmal carcinoma of the upper eyelid, Acta Ophthalmologica Scandinavica 2003; 81(5):536-8.

5. Lozano-Masdemont B, Lara Simón I y López L, Características dermatoscópicas del triquilemoma facial, Actas Dermo-Sifiliográficas 2017; 108(9):863-4.

6. Martínez-Ciarpaglini C y Monteagudo C, Pigmented desmoplastic trichilemmoma, J Cutaneous Pathol 2016; 43(6):535-7.

7. Ng D, Trichilemmoma in childhood, J Pediatric Health Care 2016; 30(5):491-4.

8. Hammami H, Benmously R, Badry T et al., Atypical clinical appearance and localization of trichilemmoma. A case report, Pathologica 2009; 101:133-4.

9. Tardío J, CD34-reactive tumors of the skin. An updated review of an ever-growing list of lesions, J Cutaneous Pathol 2009; 36(1):89-102.

10. Tsai J, Huang W, Jhuang J et al., Frequent activating HRAS mutations in trichilemmoma, Br J Dermatol 2014; 171(5): 1073-77.

11. Kurokawa I, Nishijima S, Kusumoto K et al., Trichilemmoma: an immunohistochemical study of cytokeratins, Br J Dermatol 2003; 149: 99-104.